Mexico H1N1 Vaccination Market Size & Outlook, 2026-2034


Mexico H1N1 Vaccination Market Insights

  • As highlighted in Reed Intelligence analysis, the Mexico H1N1 Vaccination Market, worth USD 132.64 Million in 2025, is forecasted to achieve USD 254.84 Million by 2034.
  • The Mexico market is anticipated to grow at a CAGR of 7.53% during the period 2026–2034.
  • By 2025, Inactivated H1N1 Vaccines represented the largest share of the Vaccine Type market size.
  • Cell-Based H1N1 Vaccines is expected to remain the key growth driver within Vaccine Type, registering the fastest CAGR during the forecast period.

Other Key Findings


  • Mexico accounted for 1.69% of the global H1N1 Vaccination Market size in 2025.
  • By 2034, United States is expected to remain the top global market in terms of size.
  • Within LATAM, Brazil is forecasted to dominate the regional H1N1 Vaccination Market size by 2034.
  • Brazil will be the fastest-growing market in LATAM, projected to achieve USD 369.57 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 132.64 Million
Market Size In 2034 USD 254.84 Million
Largest segment Inactivated H1N1 Vaccines
Units Revenue in USD Million
CAGR 7.53% (2026-2034)
Segmnetation Covered
Vaccine Type
  1. Inactivated H1N1 Vaccines
  2. Live Attenuated H1N1 Vaccines
  3. Cell-Based H1N1 Vaccines
  4. Recombinant H1N1 Vaccines
Age Group
  1. Pediatric Vaccination
  2. Adult Vaccination
  3. Geriatric Vaccination
Distribution Channel
  1. Hospital and Public Health Procurement
  2. Retail Pharmacy Distribution
  3. Online Pharmacy Channels
Route of Administration
  1. Injectable Vaccines
  2. Intranasal Vaccines
End User
  1. Public Immunization Programs
  2. Private Healthcare Providers
  3. Community Vaccination Centers
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports